• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤黑色素瘤幸存者发生第二原发性恶性肿瘤的风险:韩国一项基于全国人口的研究。

Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea.

作者信息

Jung Joon Min, Kim Do Hyung, Kim Ye-Jee, Moon Ik Jun, Lee Woo Jin, Chang Sung Eun, Lee Mi Woo, Won Chong Hyun

机构信息

Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Sci Rep. 2025 Jan 28;15(1):3541. doi: 10.1038/s41598-025-87838-3.

DOI:10.1038/s41598-025-87838-3
PMID:39875452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11775261/
Abstract

There is limited data on the risk of second primary malignancies (SPMs) in Asian melanoma survivors. This study aimed to identify the risk of SPMs in Asian melanoma survivors. Standardized incidence ratios (SIRs) were calculated for overall and specific SPMs. The risk factor for overall SPM development was analyzed using a multivariable Cox regression model. A total of 10,070 patients with melanoma were included in the study. Melanoma survivors exhibited an increased risk of overall SPM (SIR, 1.51; 95% confidence interval [CI], 1.34-1.70). Additionally, specific SPMs were more common among melanoma survivors, including nonmelanoma skin cancer, oral cavity and pharyngeal cancer, renal cancer, female breast cancer, lung cancer, pancreatic cancer, and liver cancer. Independent risk factors for overall SPM development included a Charlson Comorbidity Index ≥ 1 (adjusted hazard ratio [aHR], 1.41; 95% CI, 1.07-1.87), and a body mass index ≥ 25 kg/m (aHR, 1.47; 95% CI, 1.04-2.08). Inherent uncertainty related to diagnostic codes may exist. The risk of overall and specific SPMs was significantly elevated in Asian melanoma survivors, particularly among those with invasive melanoma. Among modifiable factors, a high body mass index (BMI) was associated with an increased risk of SPM.

摘要

关于亚洲黑色素瘤幸存者发生第二原发性恶性肿瘤(SPM)风险的数据有限。本研究旨在确定亚洲黑色素瘤幸存者发生SPM的风险。计算了总体和特定SPM的标准化发病比(SIR)。使用多变量Cox回归模型分析了总体SPM发生的危险因素。该研究共纳入10,070例黑色素瘤患者。黑色素瘤幸存者发生总体SPM的风险增加(SIR,1.51;95%置信区间[CI],1.34 - 1.70)。此外,特定的SPM在黑色素瘤幸存者中更为常见,包括非黑色素瘤皮肤癌、口腔和咽喉癌、肾癌、女性乳腺癌、肺癌、胰腺癌和肝癌。总体SPM发生的独立危险因素包括Charlson合并症指数≥1(调整后风险比[aHR],1.41;95%CI,1.07 - 1.87),以及体重指数≥25 kg/m²(aHR,1.47;95%CI,1.04 - 2.08)。可能存在与诊断编码相关的固有不确定性。亚洲黑色素瘤幸存者发生总体和特定SPM的风险显著升高,尤其是侵袭性黑色素瘤患者。在可改变的因素中,高体重指数(BMI)与SPM风险增加相关。

相似文献

1
Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea.皮肤黑色素瘤幸存者发生第二原发性恶性肿瘤的风险:韩国一项基于全国人口的研究。
Sci Rep. 2025 Jan 28;15(1):3541. doi: 10.1038/s41598-025-87838-3.
2
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?白癜风或斑秃患者中恶性黑色素瘤、角质形成细胞癌及其他癌症的发病率、分期和预后:个体内或家族性风险?
Br J Dermatol. 2025 Jun 20;193(1):66-73. doi: 10.1093/bjd/ljaf074.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.甲状腺癌放射性碘治疗后的第二原发性恶性肿瘤风险:一项系统评价和荟萃分析。
Thyroid. 2009 May;19(5):451-7. doi: 10.1089/thy.2008.0392.
5
Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression.皮肤恶性黑色素瘤患者中焦虑和抑郁的患病率和比值比:一项比例荟萃分析和回归分析。
Br J Dermatol. 2024 Jun 20;191(1):24-35. doi: 10.1093/bjd/ljae011.
6
Neoadjuvant treatment for stage III and IV cutaneous melanoma.新辅助治疗 III 期和 IV 期皮肤黑色素瘤。
Cochrane Database Syst Rev. 2023 Jan 17;1(1):CD012974. doi: 10.1002/14651858.CD012974.pub2.
7
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
8
Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.接受和未接受原发性乳腺癌术后放疗的患者发生第二种非乳腺癌的风险:一项基于人群研究的系统评价和荟萃分析,纳入522,739例患者。
Radiother Oncol. 2016 Dec;121(3):402-413. doi: 10.1016/j.radonc.2016.08.017. Epub 2016 Sep 14.
9
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
10
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.

本文引用的文献

1
Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance.肢端黑色素瘤与非肢端黑色素瘤患者基线血清中性粒细胞与淋巴细胞比值比较及其预后意义。
J Am Acad Dermatol. 2024 May;90(5):977-985. doi: 10.1016/j.jaad.2023.12.064. Epub 2024 Jan 23.
2
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management.肥胖与癌症:流行病学、发病机制、结局及管理现状综述
Cancers (Basel). 2023 Jan 12;15(2):485. doi: 10.3390/cancers15020485.
3
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.
韩国癌症统计数据:2019 年的发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2022 Apr;54(2):330-344. doi: 10.4143/crt.2022.128. Epub 2022 Mar 16.
4
Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.利用全国健康保险索赔数据评估韩国皮肤黑色素瘤的发病率和生存率。
Cancer Res Treat. 2022 Jul;54(3):937-949. doi: 10.4143/crt.2021.871. Epub 2021 Sep 30.
5
Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019.全球、区域和国家的皮肤癌发病率、死亡率和伤残调整生命年以及 1990 年至 2019 年的趋势分析:2019 年全球疾病负担研究分析。
Cancer Med. 2021 Jul;10(14):4905-4922. doi: 10.1002/cam4.4046. Epub 2021 Jun 9.
6
Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.肢端型和非肢端型黑色素瘤的不同进展模式:一项回顾性、对比、基于肿瘤部位的 492 例原发性皮肤黑色素瘤临床预后研究。
Indian J Dermatol Venereol Leprol. 2021;87(4):498-508. doi: 10.25259/IJDVL_601_19.
7
Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site.肢端和非肢端黑色素瘤中的淋巴浸润:根据肿瘤部位对原发性皮肤黑色素瘤进行的比较临床预后研究。
Pathology. 2020 Oct;52(6):670-675. doi: 10.1016/j.pathol.2020.06.011. Epub 2020 Aug 17.
8
Body mass index and height and risk of cutaneous melanoma: Mendelian randomization analyses.体质指数与身高和皮肤黑色素瘤风险:孟德尔随机分析。
Int J Epidemiol. 2020 Aug 1;49(4):1236-1245. doi: 10.1093/ije/dyaa009.
9
Genetic alterations in primary melanoma in Taiwan.台湾原发性黑色素瘤的基因改变。
Br J Dermatol. 2020 May;182(5):1205-1213. doi: 10.1111/bjd.18425. Epub 2019 Oct 15.
10
Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.回顾性队列研究中黏膜、肢端和外阴黑色素瘤的独特基因组特征。
J Am Acad Dermatol. 2023 May;88(5):1051-1059. doi: 10.1016/j.jaad.2019.07.017. Epub 2019 Jul 12.